Michael Dunn Reflects on all ASH25 Represents for the Bleeding Disorders Community
Michael Dunn, Vice President – Head of Rare Disease Portfolio at Genentech, shared on LinkedIn:
”I’m pausing to take a moment to reflect on all ASH25 represents for the bleeding disorders community – innovation, hope, progress.
I feel energized to be here.
Connecting with brilliant minds, learning about the latest advancements in hematology, and sharing how Genentech is advancing the standard of care for patients and their families.
I’m proud to be part of an organization that prioritizes standing alongside the hemophilia A community.
Every step forward is driven by our commitment to push the boundaries of what’s possible and deliver meaningful progress for people living with bleeding disorders.
A big thank you to the local Florida team for their above and beyond efforts at the booth Jeremy V., Lucila Ramirez Donaldson, William Lopez and to members of the leadership team who were representing our collective efforts for those with bleeding disorders Erik Lundgren, Tony Lin, Juliana Lagrasta Biondo, Gina Noh”
All from ASH25 featured in Hemostasis Today.
-
Dec 9, 2025, 04:47Grigoris Gerotziafas: 3 ASH 2025 Poster Awards for Our Team!
-
Dec 9, 2025, 04:36Nathan Connell on the 1st von Willebrand Factor/Factor VIII Relevance Academy
-
Dec 9, 2025, 04:22Ibtesam Alsufyani on RBC Exchange: A Life-Saving Apheresis Procedure
-
Dec 9, 2025, 04:02Susan Shea on Advancement of Precision Platelet Transfusion Medicine
-
Dec 9, 2025, 03:50Ravi C Dara Shares WHO’s Phase A guidance for PBM from ISBT
-
Dec 9, 2025, 03:39Low Platelets in Pregnancy: A Clinical Reality Check from Abdul Mannan
-
Dec 9, 2025, 03:24Arun V J: Blood Loss Isn’t Always an Emergency and Blood Isn’t Always the Answer
-
Dec 8, 2025, 22:24ASH25 Day 3: Don’t Miss The Highlights
-
Dec 8, 2025, 15:09Paul Bolaji Invites You to Nigerian Stroke Leaders’ Summit 2025